99 results
Page 2 of 5
8-K
EX-99.1
mpnb3zf0i6j6b
9 May 23
Soleno Therapeutics Provides Corporate Update and Reports First Quarter 2023 Financial Results
4:06pm
8-K
EX-10.2
d7drue
19 Dec 22
Soleno Therapeutics Announces Financing Commitment for up to $60 Million
4:49pm
8-K
EX-10.1
i7dtdxqa 39i5mq6pe
19 Dec 22
Soleno Therapeutics Announces Financing Commitment for up to $60 Million
4:49pm
8-K
dasf w9rn27
19 Dec 22
Soleno Therapeutics Announces Financing Commitment for up to $60 Million
4:49pm
8-K
EX-10.3
61thm
19 Dec 22
Soleno Therapeutics Announces Financing Commitment for up to $60 Million
4:49pm
8-K
urwo 0ujv89
30 Mar 22
Soleno Therapeutics Announces Pricing of Approximately $15 Million Underwritten Public Offering
5:24pm
8-K
EX-1.1
9ely9e1lvpbcmdf
30 Mar 22
Soleno Therapeutics Announces Pricing of Approximately $15 Million Underwritten Public Offering
5:24pm
8-K
EX-4.2
5ax9zj
30 Mar 22
Soleno Therapeutics Announces Pricing of Approximately $15 Million Underwritten Public Offering
5:24pm
8-K
EX-99.1
mr6e3my3yonpfgw
30 Mar 22
Soleno Therapeutics Announces Pricing of Approximately $15 Million Underwritten Public Offering
5:24pm
424B5
dlo0rlq5zz di90
30 Mar 22
Prospectus supplement for primary offering
5:21pm
8-K
EX-99.1
sspl1h7jnyhj ap
28 Mar 22
Soleno Therapeutics Announces Proposed Underwritten Public Offering
4:59pm
424B5
0h4pxs
28 Mar 22
Prospectus supplement for primary offering
4:53pm
8-K
g56y5l4jjyz6
16 Jul 21
Entry into a Material Definitive Agreement
4:14pm